Form 8-K Olema Pharmaceuticals, For: Jan 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- Wall St climbs after August inflation report, oil price slide
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but on track for 8% weekly gain on supply concerns; US diesel hits record high
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Olema Pharmaceuticals reports cash exceeds $500 million at year-end
January 12, 2026 4:47 PM ESTOlema Pharmaceuticals Inc. (NASDAQ: OLMA) announced its preliminary unaudited cash, cash equivalents and marketable securities exceeded $500 million as of December 31, 2025.
The company disclosed the preliminary financial figure on January 12, 2026, noting it has not completed its fiscal year-end financial close process for 2025. The... More
